Caribou Biosciences Inc.

NASDAQ: CRBU · Real-Time Price · USD
2.04
0.04 (2.00%)
At close: Aug 15, 2025, 12:52 PM

Caribou Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
9.99M 34.48M 13.85M 9.6M
Cost of Revenue
3.93M 3.52M 3.64M 984K
Gross Profit
6.07M 30.95M 10.21M 8.61M
Operating Income
-166.62M -116.06M -106.4M -66.98M
Interest Income
n/a 10.7M 4.6M 148K
Pretax Income
-149.11M -101.88M -99.35M -66.6M
Net Income
-149.1M -102.07M -99.42M -66.92M
Selling & General & Admin
46.46M 38.46M 38.02M 24.32M
Research & Development
130.15M 112.08M 82.23M 52.26M
Other Expenses
-3.93M -3.52M -3.64M -984K
Operating Expenses
172.68M 147.01M 116.61M 75.59M
Interest Expense
n/a n/a n/a 8K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
176.61M 150.54M 120.25M 76.58M
Income Tax Expense
-9K 193K 70K 321K
Shares Outstanding (Basic)
90.32M 73.81M 60.8M 60.26M
Shares Outstanding (Diluted)
90.32M 73.81M 60.8M 60.26M
EPS (Basic)
-1.65 -1.38 -1.64 -1.11
EPS (Diluted)
-1.65 -1.38 -1.64 -1.11
EBITDA
-166.62M -112.53M -104.78M -66M
EBIT
-166.62M -116.06M -106.4M -66.98M
Depreciation & Amortization
3.93M 3.52M 1.62M 984K